George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

Is D-Wave Quantum Stock a Buy?

Is Amgen Still a Top Dividend Stock?

Should You Add AT&T to Your Dividend Portfolio?

2 Disruptive Growth Stocks With Room to Run

3 Incredible Growth Stocks to Buy Right Now

7 AI Stocks I Own and Won't Stop Buying

2 Incredible Growth Stocks I Can't Stop Buying

3 Unstoppable ETFs to Buy Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.